Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-36
Closed -$1.11M 2504
2019
Q4
$1.11M Sell
36
-1
-3% -$33.9K ﹤0.01% 1862
2019
Q3
$1.32M Hold
37
﹤0.01% 1812
2019
Q2
$1.9M Sell
37
-1
-3% -$68.6K ﹤0.01% 1620
2019
Q1
$3.19M Buy
38
+1
+3% +$69.2K ﹤0.01% 1320
2018
Q4
$2.72M Sell
37
-3
-8% -$266K ﹤0.01% 1304
2018
Q3
$5M Sell
40
-9
-18% -$1.06M ﹤0.01% 1139
2018
Q2
$4.65M Sell
49
-5
-9% -$616K ﹤0.01% 1176
2018
Q1
$5.13M Sell
54
-39
-42% -$3.7M ﹤0.01% 1138
2017
Q4
$4.7M Buy
93
+4
+4% +$250K ﹤0.01% 1142
2017
Q3
$8.17M Buy
+89
New +$7.68M 0.01% 946

Other funds holding NCNA

UBS AM's NCNA Position: Q1 2020 in Review

UBS AM sold out of NuCana (NCNA) in Q1 2020, closing a stake of 36 shares — an estimated $1.11M sold.

UBS AM first reported a position in NCNA in Q3 2017 and held it in 10 quarters. The position peaked at $8.17M in Q3 2017. 16 funds tracked by Wall St. Rank hold NCNA as of Q1 2020.

  • UBS AM reported no remaining NuCana position as of Q1 2020 after selling out during the quarter.
  • UBS AM sold 36 NuCana shares in Q1 2020, an estimated $1.11M.
  • UBS AM first reported a position in NuCana in Q3 2017 and held it in 10 quarters.
  • UBS AM's NuCana position peaked at $8.17M in Q3 2017.
  • 16 funds tracked by Wall St. Rank held NuCana as of Q1 2020.

Based on UBS AM's 13F filing for Q1 2020, filed 15 May 2020.